Bernstein raised the firm’s price target on UnitedHealth (UNH) to $433 from $379 and keeps an Outperform rating on the shares going into Q3 earnings. The firm made modest changes to its EPS model, and modestly increased its target price-to-earnings to 20x, as Bernstein sees a longer period of above average EPS growth from this cyclical low.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth price target raised to $390 from $350 at BofA
- UnitedHealth price target raised to $400 from $350 at KeyBanc
- UnitedHealth’s Earnings Outlook: Balancing Potential Upside with Uncertainty
- UnitedHealth price target raised to $400 from $267 at Wells Fargo
- UNH vs. LLY vs. HIMS: Which Healthcare Stock Is the Best Pick, According to Analysts?